Background: Microbiological data of secondary wound infections following snakebites is rarely reported in Taiwan. The objective of this study was to assess the secondary wound infection after venomous snakebites. Methods: We conducted a 10-year retrospective survey on patients admitted for venomous snakebites and microbiological data of wound cultures at a medical center in northern Taiwan. Results: Between April 2001 and April 2010, 231 patients who experienced snakebites were included. Male predominated, accounting for 62.3% (144). The age range of patients was 4e95 years. Ninety-five (41.1%) people were bitten by Trimeresurus mucrosquamatus, followed by Tstejnegeri, and cobra. A total of 61 pathogens were obtained from 21 patients. Thirty-nine (63.9%) isolates were gram-negative bacteria, 14 (23%) gram-positive pathogens, and 8 (13.1%) anaerobic pathogens. There were 17 patients bitten by cobra in these 21 patients. Morganella morganii and Enterococcus species were the most common pathogens identified in the wound cultures. Conclusion: Cobra bite causes more severe bacterial infection than other kinds of snakebites. Oral amoxicillin/clavulanate plus ciprofloxacin or parenteral piperacillin/tazobactam alone can be the choices for empirical or definitive treatment, and surgical intervention should be considered for established invasive soft tissue infections.
Introduction
There are many kinds of snakes in Taiwan, including venomous and nonvenomous snakes. Six common venomous snakes include Trimeresurus mucrosquamatus, T stejnegeri, cobra, Bungarus multicinctus, Deinagkistrodon acutus, and Daboia russelii siamensis.
1e3 Snakebite is a common emergent condition. About 300e1,000 people are bitten by snakes every year. With antivenom therapy, the mortality rate has decreased from 6.6% to 1.5% since 1904. 4e6 The cause of death following snakebite is often because of a toxic hemorrhagic effect or a neurotoxic effect with secondary bacterial infection. However, bacteriological data on wound cultures following snakebite is rare in Taiwan. Hence, we surveyed the patients admitted for snakebites at our medical center in northern Taiwan in the past 10 years.
Materials and methods
Our hospital is a tertiary medical center with 3,000 beds serving for a population of 2,600,000 inhabitants in Taipei, Taiwan. We initiated our study by searching for the patient list by the ICD-9 coding, 989.5, of who experienced venomous snakebites during the period of April 2001 to April 2010. Their medical charts were reviewed.
The data on patient age, gender, time of attack and locality, body parts bitten, the snake species, and recovery conditions were collected. The snake species involved was confirmed primarily on the basis of the snake that was brought to the hospital by the patient or the family or witnessed by the patient. If the snake species could not be identified, we categorized it as a snake of unknown species.
Wound cultures were performed for patients who experienced severe wound infection during their hospital stay following the snakebite. Bacterial identification was performed using the automated system VITEK 2 (BioMérieux, Inc., Durham, NC, USA). The antimicrobial susceptibility was determined by the disc-diffusion method.
Results
In this 10-year survey, 231 patients were admitted for snakebites. Of them, 144 (62.3%) were men (Fig. 1) . The age range of patients was 4e95 years. Ninety-five (41.1%) people were bitten by T mucrosquamatus, 50 (21.6%) by T stejnegeri, 25 (10.8%) by cobra, 10 (4.3%) by B multicinctus, and 50 (21.6%) by unknown species (Table 1) .
From April to October (Spring to Summer) in northern Taiwan, 170 snakebites (73.6%) occurred (Fig. 2) . Seventyone patients received snakebites while working in a farm or field ( Table 2 ). The other places where injury occurred were the outdoor yards (63 cases), bushes or forests (45), and inside the homes (34). About 76.5% of bites that occurred inside the houses were bitten by cobra and T mucrosquamatus. Most B multicinctus (70%) bites occurred in the field and forest areas. A total of 117 patients were bitten on the lower extremities and 114 patients were bitten on the upper extremities.
All 231 cases were admitted with pain and swelling in the wounds after snakebites. After admission, 59/231 (25.5%) patients experienced cellulitis. Among them, 26/59 (44%) patients evolved into worsening wound infections and needed surgical intervention. Six needed wound incision and pus drainage, and 20 needed debridement and fascitomy for necrotizing fasciitis or compartment syndrome. The percentages of patients requiring surgery of total patients with snakebite by cobra, T mucrosquamatus, and T stejnegeri were 60% (15/25), 1% (1/96), and 0% (0/50), respectively (p < 0.001).
In Table 3 , a total of 61 bacterial pathogens were obtained from 21 patients with soft tissue infections, including 5 of 23 patients without surgery and 16 of 26 requiring surgery. Among 21 patients with microbiologically documented infections, 16 needed surgical interventions, 15 bitten by cobra and 1 by T mucrosquamatus. Four patients, two with cobra bite and two with snakebite by unknown snake species, did not have surgery. All but one of 21 patients survived, and the only fatal patient refused surgery and was discharged against advice. Of 210 patients in whom cultures were not performed, only a 23-year-old woman with breast cancer died of cobra bite.
Thirty-nine (63.9%) pathogens were gram-negative bacteria, followed by 14 (23%) that were gram-positive bacteria, and 8 (13.1%) that were anaerobic pathogens. Among gram-negative bacteria, Morganella morganii was the most common pathogen. Other important gramnegative pathogens included Pseudomonas aeruginosa and Proteus vulgaris. Enterococcus species was the most common gram-positive isolate. Bacteroides fragilis groups were the most common anaerobic pathogens. Of 21 patients with microbiologically documented pathogens, 17 patients had cobra bite, 1 was bitten by T mucrosquamatus, 1 by to T stejnegeri, and 2 by unknown species.
All gram-negative bacteria were susceptible to amikacin, ceftazidime, ciprofloxacin, and piperacillin/tazobactam (Table 4 ). All Enterococcus isolates were susceptible to vancomycin and 90% susceptible to ampicillin, and all B fragilis strains were susceptible to metronidazole, clindamycin and chloramphenicol.
Discussion
In our study, snakebite injury was more common in men. The reason may be that males had more outdoor time to work or field activity than females or because of more likely to attack or catch snakes. Such movements disturb snakes and make them more agitated causing them to attack people. A study of the seasonal distribution of snakebites indicated that snakebites occurred mainly in summer and early autumn and had a similar pattern to that described in a previous local epidemiological study on snakebites. 7, 8 A comparison of our survey with nine other studies undertaken in Taiwan since 1966 revealed that T mucrosquamatus, T stejnegeri, and cobra were the three most common snakes to attack people (Table 1) . We observed that there are more hemorrhagic snakebite cases (including T mucrosquamatus and T stejnegeri) than neurotoxic-type cases in Taiwan. T mucrosquamatus bites are the most common in north Taiwan. Cobra bites may be more common in central Taiwan. Sometimes, D acutus and D russelii siamensis bites have been reported in south Taiwan. According to our survey, cobra bites resulted in more severe complications, such as necrotizing fasciitis, compartment syndrome or rhabdomyolysis, and higher mortality rate than snakebites by other species. Fifteen of 25 people bitten by cobras needed incision, debridement, and even fasciotomy for necrotizing fasciitis and compartment syndrome. The cobra venom causes extensive local tissue destruction, mainly because of the effect of cytotoxins and myotoxic phospholipase A2. Phospholipase A2 in cobra venom was shown to have additional neuromuscular blocking activity in vitro. 9 The symptoms of neurotoxicity include ptosis, ophthalmoplegia, dysphagia, flaccid paralysis, respiratory paralysis, and coma. 10 A previous study showed that Naja atra bites induced neurotoxicity with muscle weakness in 15% (4/27) of the patients. 11 However, in our study, only one patient (1/50) experienced dizziness and vomiting after a cobra bite. The venom of cobra also showed significant hemolytic activity in animal studies. This may be because of the synergistic effect of cardiotoxin and phospholipase A2. 12, 13 Mixed bacterial infections were commonly observed in wound cultures with a combination of gram-positive, gramnegative, and anaerobic microorganisms. M morganii and Enterococcus species were the most common pathogens, especially in the cobra oral cavities, 8, 14 as noted in the present study. Among aerobic gram-negative bacteria identified, M morganii was reported to be the main pathogenic organism in many bacteriological studies involving cases of snakebite wound abscesses. 15, 16 More than threequarters (76%, 13/17) of the wounds caused by cobras bites were colonized or infected by this pathogen, which was susceptible to amikacin, ceftazidime, ciprofloxacin, and piperacillin/tazobactam.
After snakebite, early use of antivenom showed a trend toward a better local outcome within 12 hours. Prophylactic use of antibiotics was still controversial. 16 In our study, cobra bite-related injuries were more severe than other species. Some studies suggested empirical antibiotic treatment for wound infections by cobra. 8, 14 For minor wound infections, oral amoxicillin/clavulanate plus ciprofloxacin may be considered and for severe wound infections, parenteral piperacillin/tazobactam may be the choice for polymicrobial infections caused by snakebites. In summary, snakebites, especially cobra snakebite, may cause serious local complications. Oral amoxicillin/clavulanate plus ciprofloxacin or parenteral piperacillin/tazobactam alone can be the choices for empirical or definitive treatment, and surgical intervention should be considered for established invasive soft tissue infections. 14 (100) 2 (14) 14 (100) 14 (100) 9 (64) 14 (100) 14 (100) 14 (100) 14 (100) 14 (100) 14 (100) 14 ( Citrobacter species (4) 3 (75) 3 (75) 4 (100) 4 (100) 4 (100) 4 (100) 4 (100) 4 (100) 4 (100) 4 (100) 4 (100)
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